Sustained protein synthesis and reduced eEF2K levels in TAp73^-\- mice brain: a possible compensatory mechanism

References

• Dotsch V, Bernassola F, Coutandin D, et al. p63 and p73, the ancestors of p53. Cold Spring Harb Perspect Biol. 2010;2(9):a004887.
   PubMed Web of Science ®Google Scholar
• Van Nostrand JL, Bowen ME, Vogel H, et al. The p53 family members have distinct roles during mammalian embryonic development. Cell Death Differ. 2017;24(4):575–579.
   PubMed Web of Science ®Google Scholar
• Vikhreva P, Melino G, Amelio I. p73 alternative splicing: exploring a biological role for the C-terminal isoforms. J Mol Biol. 2018;430(13):1829–1838.
   PubMed Web of Science ®Google Scholar
• Tomasini R, Tsuchihara K, Wilhelm M, et al. TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev. 2008;22(19):2677–2691.
   PubMed Web of Science ®Google Scholar
• Amelio I, Inoue S, Markert EK, et al. TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1alpha degradation. Proc Natl Acad Sci U S A. 2015;112(1):226–231.
   PubMed Web of Science ®Google Scholar
• Vikhreva P, Petrova V, Gokbulut T, et al. TAp73 upregulates IL-1beta in cancer cells: potential biomarker in lung and breast cancer? Biochem Biophys Res Commun. 2017;482(3):498–505.
   PubMed Web of Science ®Google Scholar
• Amelio I, Melino G. The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression. Trends Biochem Sci. 2015;40(8):425–434.
   PubMed Web of Science ®Google Scholar
• Thakur AK, Nigri J, Lac S, et al. TAp73 loss favors Smad-independent TGF-beta signaling that drives EMT in pancreatic ductal adenocarcinoma. Cell Death Differ. 2016;23(8):1358–1370.
   PubMed Web of Science ®Google Scholar
• Rufini A, Niklison-Chirou MV, Inoue S, et al. TAp73 depletion accelerates aging through metabolic dysregulation. Genes Dev. 2012;26(18):2009–2014.
   PubMed Web of Science ®Google Scholar
• Amelio I, Antonov AA, Catani MV, et al. TAp73 promotes anabolism. Oncotarget. 2014;5(24):12820–12934.
   PubMedGoogle Scholar
• Amelio I, Cutruzzola F, Antonov A, et al. Serine and glycine metabolism in cancer. Trends Biochem Sci. 2014;39(4):191–198.
   PubMed Web of Science ®Google Scholar
• Du W, Jiang P, Mancuso A, et al. TAp73 enhances the pentose phosphate pathway and supports cell proliferation. Nat Cell Biol. 2013;15(8):991–1000.
   PubMed Web of Science ®Google Scholar
• Sharif T, Ahn D-G, Liu R-Z, et al. The NAD(+) salvage pathway modulates cancer cell viability via p73. Cell Death Differ. 2016;23(4):669–680.
   PubMed Web of Science ®Google Scholar
• Niklison-Chirou MV, Erngren I, Engskog M, et al. TAp73 is a marker of glutamine addiction in medulloblastoma. Genes Dev. 2017;31(17):1738–1753.
   PubMed Web of Science ®Google Scholar
• Agostini M, Romeo F, Inoue S, et al. Metabolic reprogramming during neuronal differentiation. Cell Death Differ. 2016;23(9):1502–1514.
   PubMed Web of Science ®Google Scholar
• Nemajerova A, Amelio I, Gebel J, et al. Non-oncogenic roles of TAp73: from multiciliogenesis to metabolism. Cell Death Differ. 2018;25(1):144–153.
   PubMed Web of Science ®Google Scholar
• Inoue S, Tomasini R, Rufini A, et al. TAp73 is required for spermatogenesis and the maintenance of male fertility. Proc Natl Acad Sci U S A. 2014;111(5):1843–1848.
   PubMed Web of Science ®Google Scholar
• Belyi VA, Ak P, Markert E, et al. The origins and evolution of the p53 family of genes. Cold Spring Harb Perspect Biol. 2010;2(6):a001198.
   PubMed Web of Science ®Google Scholar
• Martin-Lopez M, Nikolic A, Kentish SJ, et al. p73 is required for appropriate BMP-induced mesenchymal-to-epithelial transition during somatic cell reprogramming. Cell Death Dis. 2017;8(9):e3034.
   PubMedGoogle Scholar
• Bieging KT, Mello SS, Attardi LD. Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer. 2014;14(5):359–370.
   PubMed Web of Science ®Google Scholar
• Garcia PB, Attardi LD. Illuminating p53 function in cancer with genetically engineered mouse models. Semin Cell Dev Biol. 2014;27:74–85.
   PubMed Web of Science ®Google Scholar
• Murphy ME. Ironing out how p53 regulates ferroptosis. Proc Natl Acad Sci U S A. 2016;113(44):12350–12352.
   PubMed Web of Science ®Google Scholar
• Fouchecourt S, Livera G, Messiaen S, et al. Apoptosis of Sertoli cells after conditional ablation of murine double minute 2 (Mdm2) gene is p53-dependent and results in male sterility. Cell Death Differ. 2016;23(3):521–530.
   PubMed Web of Science ®Google Scholar
• Belle JI, Petrov JC, Langlais D, et al. Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance. Cell Death Differ. 2016;23(5):759–775.
   PubMed Web of Science ®Google Scholar
• Pfister NT, Prives C. Transcriptional regulation by wild-type and cancer-related mutant forms of p53. Cold Spring Harb Perspect Med. 2017;7(2).
   PubMed Web of Science ®Google Scholar
• Gudkov AV, Komarova EA. p53 and the carcinogenicity of chronic inflammation. Cold Spring Harb Perspect Med. 2016;6(11).
   PubMed Web of Science ®Google Scholar
• Jennis M, Kung CP, Basu S, et al. An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model. Genes Dev. 2016;30(8):918–930.
   PubMed Web of Science ®Google Scholar
• Velletri T, Xie N, Wang Y, et al. P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma development. Cell Death Dis. 2016;7:e2015.
   PubMed Web of Science ®Google Scholar
• Pinto M, Pickrell AM, Wang X, et al. Transient mitochondrial DNA double strand breaks in mice cause accelerated aging phenotypes in a ROS-dependent but p53/p21-independent manner. Cell Death Differ. 2017;24(2):288–299.
   PubMed Web of Science ®Google Scholar
• Muller PA, Vousden KH. Mutant p53 in cancer: new functions and therapeutic opportunities. Cancer Cell. 2014;25(3):304–317.
   PubMed Web of Science ®Google Scholar
• Alexandrova EM, Moll UM. Depleting stabilized GOF mutant p53 proteins by inhibiting molecular folding chaperones: a new promise in cancer therapy. Cell Death Differ. 2017;24(1):3–5.
   PubMed Web of Science ®Google Scholar
• Gurpinar E, Vousden KH. Hitting cancers’ weak spots: vulnerabilities imposed by p53 mutation. Trends Cell Biol. 2015;25(8):486–495.
   PubMed Web of Science ®Google Scholar
• Muller PA, Caswell PT, Doyle B, et al. Mutant p53 drives invasion by promoting integrin recycling. Cell. 2009;139(7):1327–1341.
   PubMed Web of Science ®Google Scholar
• Charni M, Aloni-Grinstein R, Molchadsky A, et al. p53 on the crossroad between regeneration and cancer. Cell Death Differ. 2017;24(1):8–14.
   PubMed Web of Science ®Google Scholar
• Kehrloesser S, Osterburg C, Tuppi M, et al. Intrinsic aggregation propensity of the p63 and p73 TI domains correlates with p53R175H interaction and suggests further significance of aggregation events in the p53 family. Cell Death Differ. 2016;23(12):1952–1960.
   PubMed Web of Science ®Google Scholar
• Gebel J, Luh LM, Coutandin D, et al. Mechanism of TAp73 inhibition by DeltaNp63 and structural basis of p63/p73 hetero-tetramerization. Cell Death Differ. 2016;23(12):1930–1940.
   PubMed Web of Science ®Google Scholar
• Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 1999;398(6729):714–718.
   PubMed Web of Science ®Google Scholar
• Vanbokhoven H, Melino G, Candi E, et al. p63, a story of mice and men. J Invest Dermatol. 2011;131(6):1196–1207.
   PubMed Web of Science ®Google Scholar
• Candi E, Amelio I, Agostini M, et al. MicroRNAs and p63 in epithelial stemness. Cell Death Differ. 2015;22(1):12–21.
   PubMed Web of Science ®Google Scholar
• Rivetti Di Val Cervo P, Lena AM, Nicoloso M, et al. p63-microRNA feedback in keratinocyte senescence. Proc Natl Acad Sci U S A. 2012;109(4):1133–1138.
   PubMed Web of Science ®Google Scholar
• Melino G, Memmi EM, Pelicci PG, et al. Maintaining epithelial stemness with p63. Sci Signal. 2015;8(387):re9.
   PubMed Web of Science ®Google Scholar
• Lohrum MA, Vousden KH. Regulation and function of the p53-related proteins: same family, different rules. Trends Cell Biol. 2000;10(5):197–202.
   PubMed Web of Science ®Google Scholar
• Berkers CR, Maddocks OD, Cheung EC, et al. Metabolic regulation by p53 family members. Cell Metab. 2013;18(5):617–633.
   PubMed Web of Science ®Google Scholar
• Rufini S, Lena AM, Cadot B, et al. The sterile alpha-motif (SAM) domain of p63 binds in vitro monoasialoganglioside (GM1) micelles. Biochem Pharmacol. 2011;82(10):1262–1268.
   PubMed Web of Science ®Google Scholar
• Viticchie G, Agostini M, Lena AM, et al. p63 supports aerobic respiration through hexokinase II. Proc Natl Acad Sci U S A. 2015;112(37):11577–11582.
   PubMed Web of Science ®Google Scholar
• Vigano MA, Lamartine J, Testoni B, et al. New p63 targets in keratinocytes identified by a genome-wide approach. Embo J. 2006;25(21):5105–5116.
   PubMed Web of Science ®Google Scholar
• Lena AM, Cipollone R, Amelio I, et al. Skn-1a/Oct-11 and DeltaNp63alpha exert antagonizing effects on human keratin expression. Biochem Biophys Res Commun. 2010;401(4):568–573.
   PubMed Web of Science ®Google Scholar
• Celardo I, Antonov A, Amelio I, et al. p63 transcriptionally regulates the expression of matrix metallopeptidase 13. Oncotarget. 2014;5(5):1279–1289.
   PubMedGoogle Scholar
• Memmi EM, Sanarico AG, Giacobbe A, et al. p63 Sustains self-renewal of mammary cancer stem cells through regulation of Sonic Hedgehog signaling. Proc Natl Acad Sci U S A. 2015;112(11):3499–3504.
   PubMed Web of Science ®Google Scholar
• Celardo I, Grespi F, Antonov A, et al. Caspase-1 is a novel target of p63 in tumor suppression. Cell Death Dis. 2013;4:e645.
   PubMed Web of Science ®Google Scholar
• D’Alessandro A, Amelio I, Berkers CR, et al. Metabolic effect of TAp63alpha: enhanced glycolysis and pentose phosphate pathway, resulting in increased antioxidant defense. Oncotarget. 2014;5(17):7722–7733.
   PubMedGoogle Scholar
• Giacobbe A, Bongiorno-Borbone L, Bernassola F, et al. p63 regulates glutaminase 2 expression. Cell Cycle. 2013;12(9):1395–1405.
   PubMed Web of Science ®Google Scholar
• Regina C, Nikolic A, Kentish SJ, et al. DeltaNp63alpha modulates histone methyl transferase SETDB1 to transcriptionally repress target genes in cancers. Cell Death Discov. 2016;2:16015.
   PubMedGoogle Scholar
• Compagnone M, Gatti V, Presutti D, et al. DeltaNp63-mediated regulation of hyaluronic acid metabolism and signaling supports HNSCC tumorigenesis. Proc Natl Acad Sci U S A. 2017;114(50):13254–13259.
   PubMed Web of Science ®Google Scholar
• Amelio I, Melino G, Candi E. p63 adjusts sugar taste of epidermal layers. J Invest Dermatol. 2017;137(6):1204–1206.
   PubMed Web of Science ®Google Scholar
• Niklison-Chirou MV, Killick R, Knight RA, et al. How does p73 cause neuronal defects? Mol Neurobiol. 2016;53(7):4509–4520.
   PubMed Web of Science ®Google Scholar
• Turnquist C, Horikawa I, Foran E, et al. p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration. Cell Death Differ. 2016;23(9):1515–1528.
   PubMed Web of Science ®Google Scholar
• Xie N, Vikhreva P, Annicchiarico-Petruzzelli M, et al. Integrin-beta4 is a novel transcriptional target of TAp73. Cell Cycle. 2018;17(5):589–594.
   PubMed Web of Science ®Google Scholar
• Pozniak CD, Radinovic S, Yang A, et al. An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science. 2000;289(5477):304–306.
   PubMed Web of Science ®Google Scholar
• Niklison-Chirou MV, Steinert JR, Agostini M, et al. TAp73 knockout mice show morphological and functional nervous system defects associated with loss of p75 neurotrophin receptor. Proc Natl Acad Sci U S A. 2013;110(47):18952–18957.
   PubMed Web of Science ®Google Scholar
• Agostini M, Tucci P, Killick R, et al. Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets. Proc Natl Acad Sci U S A. 2011;108(52):21093–21098.
   PubMed Web of Science ®Google Scholar
• Yang A, Walker N, Bronson R, et al. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature. 2000;404(6773):99–103.
   PubMed Web of Science ®Google Scholar
• Nemajerova A, Kramer D, Siller SS, et al. TAp73 is a central transcriptional regulator of airway multiciliogenesis. Genes Dev. 2016;30(11):1300–1312.
   PubMed Web of Science ®Google Scholar
• Marshall CB, Mays DJ, Beeler JS, et al. p73 is required for multiciliogenesis and regulates the Foxj1-associated gene network. Cell Rep. 2016;14(10):2289–2300.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Cano L, Fuertes-Alvarez S, Robledinos-Anton N, et al. p73 is required for ependymal cell maturation and neurogenic SVZ cytoarchitecture. Dev Neurobiol. 2016;76(7):730–747.
   PubMed Web of Science ®Google Scholar
• Jackson PK, Attardi LD. p73 and FoxJ1: programming multiciliated epithelia. Trends Cell Biol. 2016;26(4):239–240.
   PubMed Web of Science ®Google Scholar
• Candi E, Agostini M, Melino G, et al. How the TP53 family proteins TP63 and TP73 contribute to tumorigenesis: regulators and effectors. Hum Mutat. 2014;35(6):702–714.
   PubMed Web of Science ®Google Scholar
• Marini A, Rotblat B, Sbarrato T, et al. TAp73 contributes to the oxidative stress response by regulating protein synthesis. Proc Natl Acad Sci U S A. 2018;115(24):6219–6224.
   PubMed Web of Science ®Google Scholar
• Blagden SP, Willis AE. The biological and therapeutic relevance of mRNA translation in cancer. Nat Rev Clin Oncol. 2011;8(5):280–291.
   PubMed Web of Science ®Google Scholar
• Zhao BS, Roundtree IA, He C. Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2017;18(1):31–42.
   PubMed Web of Science ®Google Scholar
• Delaidelli A, Negri GL, Jan A, et al. MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation. Cell Death Differ. 2017;24(9):1564–1576.
   PubMed Web of Science ®Google Scholar
• Schmidt EK, Clavarino G, Ceppi M, et al. SUnSET, a nonradioactive method to monitor protein synthesis. Nat Methods. 2009;6(4):275–277.
   PubMed Web of Science ®Google Scholar
• Trinh MA, Ma T, Kaphzan H, et al. The eIF2alpha kinase PERK limits the expression of hippocampal metabotropic glutamate receptor-dependent long-term depression. Learn Mem. 2014;21(5):298–304.
   PubMed Web of Science ®Google Scholar
• Liu R, Iadevaia V, Averous J, et al. Impairing the production of ribosomal RNA activates mammalian target of rapamycin complex 1 signalling and downstream translation factors. Nucleic Acids Res. 2014;42(8):5083–5096.
   PubMed Web of Science ®Google Scholar
• Pelletier J, Thomas G, Volarevic S. Ribosome biogenesis in cancer: new players and therapeutic avenues. Nat Rev Cancer. 2018;18(1):51–63.
   PubMed Web of Science ®Google Scholar
• Velletri T, Romeo F, Tucci P, et al. GLS2 is transcriptionally regulated by p73 and contributes to neuronal differentiation. Cell Cycle. 2013;12(22):3564–3573.
   PubMed Web of Science ®Google Scholar
• Amelio I, Markert EK, Rufini A, et al. p73 regulates serine biosynthesis in cancer. Oncogene. 2014;33(42):5039–5046.
   PubMed Web of Science ®Google Scholar
• Raimundo N. Mitochondrial pathology: stress signals from the energy factory. Trends Mol Med. 2014;20(5):282–292.
   PubMed Web of Science ®Google Scholar
• Wang SB, Murray CI, Chung HS, et al. Redox regulation of mitochondrial ATP synthase. Trends Cardiovasc Med. 2013;23(1):14–18.
   PubMed Web of Science ®Google Scholar
• Garedew A, Henderson SO, Moncada S. Activated macrophages utilize glycolytic ATP to maintain mitochondrial membrane potential and prevent apoptotic cell death. Cell Death Differ. 2017;24(6):1132.
   PubMed Web of Science ®Google Scholar
• Van Aken O, Pogson BJ. Convergence of mitochondrial and chloroplastic ANAC017/PAP-dependent retrograde signalling pathways and suppression of programmed cell death. Cell Death Differ. 2017;24(6):955–960.
   PubMed Web of Science ®Google Scholar
• Prola A, Da Silva JP, Guilbert A, et al. SIRT1 protects the heart from ER stress-induced cell death through eIF2alpha deacetylation. Cell Death Differ. 2017;24(2):343–356.
   PubMed Web of Science ®Google Scholar
• Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12(12):931–947.
   PubMed Web of Science ®Google Scholar
• Winterbourn CC. Reconciling the chemistry and biology of reactive oxygen species. Nat Chem Biol. 2008;4(5):278–286.
   PubMed Web of Science ®Google Scholar
• Dong Z, Huang M, Liu Z, et al. Focused screening of mitochondrial metabolism reveals a crucial role for a tumor suppressor Hbp1 in ovarian reserve. Cell Death Differ. 2016;23(10):1602–1614.
   PubMed Web of Science ®Google Scholar
• Caputa G, Zhao S, Criado AEG, et al. RNASET2 is required for ROS propagation during oxidative stress-mediated cell death. Cell Death Differ. 2016;23(2):347–357.
   PubMed Web of Science ®Google Scholar
• Sayan AE, Paradisi A, Vojtesek B, et al. New antibodies recognizing p73: comparison with commercial antibodies. Biochem Biophys Res Commun. 2005;330(1):186–193.
   PubMed Web of Science ®Google Scholar